India’s Market Focus Of U.K.’s GSK For Acquisitions, New Products
This article was originally published in PharmAsia News
Executive Summary
India's drug market is the target of an effort by U.K.-based GlaxoSmithKline Pharmaceuticals to establish a foothold, primarily through acquisitions and new products